Marchés français ouverture 7 h 34 min
  • Dow Jones

    30 960,00
    -36,98 (-0,12 %)
     
  • Nasdaq

    13 635,99
    +92,93 (+0,69 %)
     
  • Nikkei 225

    28 724,20
    -98,09 (-0,34 %)
     
  • EUR/USD

    1,2142
    -0,0003 (-0,02 %)
     
  • HANG SENG

    30 159,01
    +711,16 (+2,41 %)
     
  • BTC-EUR

    26 834,63
    +397,71 (+1,50 %)
     
  • CMC Crypto 200

    653,79
    -23,11 (-3,41 %)
     
  • S&P 500

    3 855,36
    +13,89 (+0,36 %)
     

Global Viral Hepatitis and Retrovirus Diagnostic Tests Industry

ReportLinker
·14 min de lecture

Global Viral Hepatitis and Retrovirus Diagnostic Tests Market to Reach $5. 9 Billion by 2027. Amid the COVID-19 crisis, the global market for Viral Hepatitis and Retrovirus Diagnostic Tests estimated at US$3.

New York, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Viral Hepatitis and Retrovirus Diagnostic Tests Industry" - https://www.reportlinker.com/p05960424/?utm_source=GNW
3 Billion in the year 2020, is projected to reach a revised size of US$5.9 Billion by 2027, growing at a CAGR of 8.5% over the period 2020-2027.

The U.S. Market is Estimated at $898.1 Million, While China is Forecast to Grow at 11.4% CAGR

The Viral Hepatitis and Retrovirus Diagnostic Tests market in the U.S. is estimated at US$898.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2027 trailing a CAGR of 11.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 7.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR.We bring years of research experience to this 9th edition of our report. The 127-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Diagnostics

  • Chembio Diagnostic Systems, Inc.

  • DiaSorin SpA

  • Roche Diagnostics (Schweiz) AG




Read the full report: https://www.reportlinker.com/p05960424/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Viral Hepatitis and Retrovirus Diagnostic Tests Competitor
Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Viral Hepatitis
and Retrovirus Diagnostic Tests by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027

Table 2: World Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019

Table 3: World 15-Year Perspective for Viral Hepatitis and
Retrovirus Diagnostic Tests by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Viral Hepatitis and Retrovirus Diagnostic Tests Market Share
(in %) by Company: 2019 & 2025
Market Analytics
Table 4: USA Current & Future Analysis for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 5: USA Historic Review for Viral Hepatitis and Retrovirus
Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus
Diagnostic Tests Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

CANADA
Table 6: Canada Current & Future Analysis for Viral Hepatitis
and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 7: Canada Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

JAPAN
Table 8: Japan Current & Future Analysis for Viral Hepatitis
and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 9: Japan Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

CHINA
Table 10: China Current & Future Analysis for Viral Hepatitis
and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 11: China Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

EUROPE
Market Facts & Figures
European Viral Hepatitis and Retrovirus Diagnostic Tests
Market: Competitor Market Share Scenario (in %) for 2019 &
2025
Market Analytics
Table 12: Europe Current & Future Analysis for Viral Hepatitis
and Retrovirus Diagnostic Tests by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 13: Europe Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 14: Europe 15-Year Perspective for Viral Hepatitis and
Retrovirus Diagnostic Tests by Geographic Region - Percentage
Breakdown of Value Sales for France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets for Years 2012, 2020 & 2027

FRANCE
Table 15: France Current & Future Analysis for Viral Hepatitis
and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 16: France Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

GERMANY
Table 17: Germany Current & Future Analysis for Viral Hepatitis
and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 18: Germany Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

ITALY
Table 19: Italy Current & Future Analysis for Viral Hepatitis
and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 20: Italy Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

UNITED KINGDOM
Table 21: UK Current & Future Analysis for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 22: UK Historic Review for Viral Hepatitis and Retrovirus
Diagnostic Tests by Segment - Viral Hepatitis & Retrovirus
Diagnostic Tests Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

SPAIN
Table 23: Spain Current & Future Analysis for Viral Hepatitis
and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 24: Spain Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

RUSSIA
Table 25: Russia Current & Future Analysis for Viral Hepatitis
and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 26: Russia Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

REST OF EUROPE
Table 27: Rest of Europe Current & Future Analysis for Viral
Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral
Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 28: Rest of Europe Historic Review for Viral Hepatitis
and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

ASIA-PACIFIC
Table 29: Asia-Pacific Current & Future Analysis for Viral
Hepatitis and Retrovirus Diagnostic Tests by Geographic Region -
Australia, India, South Korea and Rest of Asia-Pacific
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027

Table 30: Asia-Pacific Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Geographic Region - Australia,
India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 31: Asia-Pacific 15-Year Perspective for Viral Hepatitis
and Retrovirus Diagnostic Tests by Geographic Region -
Percentage Breakdown of Value Sales for Australia, India, South
Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 &
2027

AUSTRALIA
Table 32: Australia Current & Future Analysis for Viral
Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral
Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 33: Australia Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

INDIA
Table 34: India Current & Future Analysis for Viral Hepatitis
and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 35: India Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

SOUTH KOREA
Table 36: South Korea Current & Future Analysis for Viral
Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral
Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 37: South Korea Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

REST OF ASIA-PACIFIC
Table 38: Rest of Asia-Pacific Current & Future Analysis for
Viral Hepatitis and Retrovirus Diagnostic Tests by Segment -
Viral Hepatitis & Retrovirus Diagnostic Tests - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 39: Rest of Asia-Pacific Historic Review for Viral
Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral
Hepatitis & Retrovirus Diagnostic Tests Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

LATIN AMERICA
Table 40: Latin America Current & Future Analysis for Viral
Hepatitis and Retrovirus Diagnostic Tests by Geographic Region -
Argentina, Brazil, Mexico and Rest of Latin America Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 41: Latin America Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Geographic Region - Argentina,
Brazil, Mexico and Rest of Latin America Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 42: Latin America 15-Year Perspective for Viral Hepatitis
and Retrovirus Diagnostic Tests by Geographic Region -
Percentage Breakdown of Value Sales for Argentina, Brazil,
Mexico and Rest of Latin America Markets for Years 2012, 2020 &
2027

ARGENTINA
Table 43: Argentina Current & Future Analysis for Viral
Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral
Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 44: Argentina Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

BRAZIL
Table 45: Brazil Current & Future Analysis for Viral Hepatitis
and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 46: Brazil Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

MEXICO
Table 47: Mexico Current & Future Analysis for Viral Hepatitis
and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 48: Mexico Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

REST OF LATIN AMERICA
Table 49: Rest of Latin America Current & Future Analysis for
Viral Hepatitis and Retrovirus Diagnostic Tests by Segment -
Viral Hepatitis & Retrovirus Diagnostic Tests - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 50: Rest of Latin America Historic Review for Viral
Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral
Hepatitis & Retrovirus Diagnostic Tests Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

MIDDLE EAST
Table 51: Middle East Current & Future Analysis for Viral
Hepatitis and Retrovirus Diagnostic Tests by Geographic Region -
Iran, Israel, Saudi Arabia, UAE and Rest of Middle East
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027

Table 52: Middle East Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Geographic Region - Iran,
Israel, Saudi Arabia, UAE and Rest of Middle East Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 53: Middle East 15-Year Perspective for Viral Hepatitis
and Retrovirus Diagnostic Tests by Geographic Region -
Percentage Breakdown of Value Sales for Iran, Israel, Saudi
Arabia, UAE and Rest of Middle East Markets for Years 2012,
2020 & 2027

IRAN
Table 54: Iran Current & Future Analysis for Viral Hepatitis
and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 55: Iran Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

ISRAEL
Table 56: Israel Current & Future Analysis for Viral Hepatitis
and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 57: Israel Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

SAUDI ARABIA
Table 58: Saudi Arabia Current & Future Analysis for Viral
Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral
Hepatitis & Retrovirus Diagnostic Tests - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 59: Saudi Arabia Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

UNITED ARAB EMIRATES
Table 60: UAE Current & Future Analysis for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 61: UAE Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

REST OF MIDDLE EAST
Table 62: Rest of Middle East Current & Future Analysis for
Viral Hepatitis and Retrovirus Diagnostic Tests by Segment -
Viral Hepatitis & Retrovirus Diagnostic Tests - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 63: Rest of Middle East Historic Review for Viral
Hepatitis and Retrovirus Diagnostic Tests by Segment - Viral
Hepatitis & Retrovirus Diagnostic Tests Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

AFRICA
Table 64: Africa Current & Future Analysis for Viral Hepatitis
and Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 65: Africa Historic Review for Viral Hepatitis and
Retrovirus Diagnostic Tests by Segment - Viral Hepatitis &
Retrovirus Diagnostic Tests Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

IV. COMPETITION
Total Companies Profiled: 31
Read the full report: https://www.reportlinker.com/p05960424/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001